russ2000_2_0558|SCPH|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0558|SCPH|Long Name|scPharmaceuticals Inc Total Current Assets (Quarterly) (USD)|scPharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|scPharmaceuticals Inc Inventories (Quarterly) (USD)|scPharmaceuticals Inc Net PP&E (Quarterly) (USD)|scPharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|scPharmaceuticals Inc Total Liabilities (Quarterly) (USD)|scPharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|scPharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|scPharmaceuticals Inc Total Deposits (Quarterly) (USD)|scPharmaceuticals Inc Book Value (Quarterly) (USD)|scPharmaceuticals Inc Retained Earnings (Quarterly) (USD)|scPharmaceuticals Inc Treasury Stock (Quarterly) (USD)|scPharmaceuticals Inc EV to Revenues|scPharmaceuticals Inc EV to Earnings|scPharmaceuticals Inc EV to Free Cash Flow|scPharmaceuticals Inc EV to Assets (Quarterly)|scPharmaceuticals Inc PS Ratio|scPharmaceuticals Inc PE Ratio|scPharmaceuticals Inc Price to Book Value|scPharmaceuticals Inc PEG Ratio|scPharmaceuticals Inc Debt to Equity Ratio|scPharmaceuticals Inc Dividend Yield|scPharmaceuticals Inc Shareholder Yield (TTM)|scPharmaceuticals Inc Percent of Shares Outstanding Short|scPharmaceuticals Inc Total Receivables (Quarterly) (USD)|scPharmaceuticals Inc Total Payables (Quarterly) (USD)|scPharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|scPharmaceuticals Inc Return on Invested Capital|scPharmaceuticals Inc Quality Ratio Score|scPharmaceuticals Inc Momentum Score|scPharmaceuticals Inc Beta (1Y)|scPharmaceuticals Inc Sustainable Growth Rate (TTM)|scPharmaceuticals Inc Institutional Investor Ownership Percentage|scPharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|scPharmaceuticals Inc Total Employees (Annual)|scPharmaceuticals Inc EPS Diluted (Quarterly) (USD)|scPharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|scPharmaceuticals Inc Revenue (Quarterly) (USD)|scPharmaceuticals Inc Gross Profit (Quarterly) (USD)|scPharmaceuticals Inc SG&A Expense (Quarterly) (USD)|scPharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|scPharmaceuticals Inc Net Income (Quarterly) (USD)|scPharmaceuticals Inc Net Interest Income (Quarterly) (USD)|scPharmaceuticals Inc Price (USD)|scPharmaceuticals Inc Total Return Price (USD)|scPharmaceuticals Inc Enterprise Value (USD)|scPharmaceuticals Inc 30-Day Average Daily Volume|scPharmaceuticals Inc 1 Year Price Returns (Daily)||
russ2000_2_0558|SCPH|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0558|SCPH|201612|39.74|39.282||0.026||76.846|3.736|73.11||-37.074|-43.199||||||||||||||0.349|1.565|0|||||||11.2015||-0.4748||||0.943|-5.318|-5.318|-1.385|||||||
russ2000_2_0558|SCPH|201703||||||||||||||||||||||||||||||||||11.2015||-0.4385||||2.074|-4.912|-4.912|0.037|||||||
russ2000_2_0558|SCPH|201706||||||||||||||||||||||||||||||||||11.2015||-0.5835||||2.374|-6.536|-6.536|-0.074|||||||
russ2000_2_0558|SCPH|201709|33.538|31.435||0.209||14.28|4.832|9.448||19.654|-60.143||||||||||||||0.685|1.01|0.001|||||||17.6102|28|-0.3117||||1.665|-5.489|-5.489|-0.254||||||14.1|14.1
russ2000_2_0558|SCPH|201712|119.883|118.298||1.976||16.051|5.211|10.84||105.997|-67.016||||||||11.9438|||0||0.1695|0.655|1.783|0.002|||||||18.5342|29|-0.8||||2.992|-6.88|-6.88|-0.165|12.09|12.09|212.669|||11.82|11.82
russ2000_2_0558|SCPH|201803|111.568|109.28||1.895||15.708|5.8|9.908||97.944|-75.748||||-4.9239||||2.0808|||0||1.816|0.83|1.71|0.002|||||||18.5354||-0.47||||4.651|-8.732|-8.732|0.009|11.9|11.9|111.6839|71781.6333||10.98|10.98
russ2000_2_0558|SCPH|201806|102.965|100.768||1.854||16.417|7.463|8.954||88.592|-85.599||||-0.1146||||1.0507|||0||6.1696|0.438|2.44|0.002|||||||18.55|27|-0.53||||5.049|-9.85|-9.85|0.065|5.55|5.55|3.1168|225884.9333||5.88|5.88
russ2000_2_0558|SCPH|201809|96.831|95.299||1.797||15.429|7.43|7.999||83.39|-91.36||||-0.319||||1.1361|||0||5.9468|0.454|1.79|0.002|||||||18.5693||-0.31||||1.945|-5.761|-5.761|0.085|5.42|5.42|9.4396|29466.6333||4.86|4.86
russ2000_2_0558|SCPH|201812|91.893|89.478||1.67||15.011|6.673|8.338||78.744|-96.459||||0.1943||||0.9598|||0||5.9393|0.479|0.752|0.002|||1|1.3672|||18.5694|23|-0.27||||2.074|-5.1|-5.1|0.121|4.31|4.31|-5.6343|28568.9667|-68.8999|3.86|3.86
russ2000_2_0558|SCPH|201903|85.811|83.378||1.581||17.189|10.096|7.093||70.398|-105.178||||0.8913||||0.6878|||0||4.9021|0.494|0.275|0.002|||1|1.6451|||18.5757||-0.47||||2.323|-8.719|-8.719|0.136|2.915|2.915|-25.6791|21825.4|-75.8065|2.95|2.95
russ2000_2_0558|SCPH|201906|81.773|79.467||1.492||19.99|13.532|6.458||63.469|-112.433||||0.7159||||0.7839|||0||2.011|0.5|1.441|0.002|||1|0.9799|||18.5804||-0.39||||1.839|-7.255|-7.255|0.094|2.97|2.97|-18.5102|67879.7333|-44.1331|3.4|3.4
russ2000_2_0558|SCPH|201909|84.887|83.562||1.4||28.78|8.104|20.676||57.886|-118.64||||-2.2998||||1.8707|||0||0.3156|0.303|0.578|0.002|||9|1.1495||42.9885|18.5843||-0.33||||1.996|-6.207|-6.207|-0.001|6.39|6.39|48.975|60018.6333|0|5.16|5.16
russ2000_2_0558|SCPH|201912|75.647|72.624||1.306||25.918|5.237|20.681||51.365|-129.455||||-1.8462||||2.1398|||0||0.0725|0.31|1.191|0.002|||4|-1.0984||62.8498|18.6623|17|-0.58||||2.115|-10.814|-10.814|-0.336|5.66|5.66|56.2025|62495.0667|50.5319|6.07|6.07
russ2000_2_0558|SCPH|202003|79.073|75.339||1.211||25.384|4.663|20.721||55.104|-136.547||||-3.0849||||2.8177|||0||0.0456|0.305|0.713|0.002|||10|-0.1816||80.3664|20.2185||-0.35||||2.503|-7.092|-7.092|-0.412|7.4|7.4|98.9231|135329.1667|146.6667|8.07|8.07
russ2000_2_0558|SCPH|202006|122.536|119.329||1.112||25.86|5.929|19.931||98.059|-144.842||||-2.9482||||2.0482|||0||0.802|0.298|0.79|0.003|||10|0.2018||79.392|23.3554||-0.36||||2.537|-8.295|-8.295|-0.618|7.36|7.36|100.5867|190223.5667|130.721|7.28|7.28
russ2000_2_0558|SCPH|202009|||||||||||||||-3.0752||||2.0923|||0||0.8348||||||8|0.4005||79.5588|||||||||||7.51|7.51|104.9202|59551.8667|26.9165|7.66|7.66